CRV
Listed as “Axiom”
- First observed:
- 31 Oct 2026
- Investment announced:
- Date not recorded
Axiom
Axiom provides intelligence on human drug toxicity for scientists developing medicines.
- Tracked VC backers
- 1
RiseFinder summary
Axiom offers agentic intelligence that connects experimental data with human clinical results for scientists developing medicines. It focuses on human drug toxicity and aims to help scientists identify unexpected toxicity earlier.
- Company website ↗ · Checked
Tracking coverage and points
Tracking coverage
Some source history is available; coverage remains limited.
- Momentum +1 · Limited coverage
- The latest public index does not report a rank for this company.Index checked:
- Fundraising +2 · Awaiting data
- No verified dated source evidence recorded.
- New VC +3 · Awaiting data
- No verified dated source evidence recorded.
- Completed exit +10 · Limited coverage
- Homepage checked. Exit news coverage is not established.Homepage checked:
Coverage describes public evidence. Points require a qualifying milestone after your pick.
Publicly documented VC backing
These sources establish that the firm lists the company. The observation date records when RiseFinder captured the relationship; it does not establish when the investment happened.
Dated public activity
No dated funding or investment events are recorded yet. Initial portfolio listings establish the starting baseline and earn no points.